Developing a new vaccine traditionally takes years, but a response to the COVID-19 pandemic can’t wait. We’re developing our vaccine candidate with unprecedented speed, without sacrificing safety. Hear how we’re doing this in this update from our Chief Medical Officer…
Deborah Fuller’s lab has worked nonstop for months to test vaccine platforms for against SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Jesse Erasmus, senior fellow in the lab, developed what they call an “amplified RNA vaccine.” That means it…
The Department of Biotechnology under the Union Ministry of Science and Technology has announced that ZyCoV-D, the plasmid DNA vaccine candidate designed and developed by #Zydus, has entered Phase I/II clinical trials. This makes it the first indigenously developed vaccine…